Foundational laboratory studies evaluating glutathione delivery, antioxidant activity, and cellular protection. These early investigations established the scientific basis for subsequent animal and human clinical research.
The results indicate that GSH by its direct antimycobacterial activity inhibits the growth of intracellular M. tb inside DCs (dendritic cells).
No toxicity was observed with the liposomal preparation at 200-fold the EC(50) for repletion. These findings indicate that glutathione supplied in a liposomal formulation holds promise as a potential therapeutic for neuronal maintenance. PMID: Read the Article